Kondo Yusuke, Ueda Marehiko, Winter Joachim, Nakano Miyo, Nakano Masahiro, Ishimura Masayuki, Miyazawa Kazuo, Tateno Kaoru, Kobayashi Yoshio
Department of Advanced Cardiovascular Therapeutics, Chiba University Graduate School of Medicine, Chiba, Japan.
Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
J Arrhythm. 2017 Feb;33(1):63-65. doi: 10.1016/j.joa.2016.04.005. Epub 2016 Jun 1.
The entirely subcutaneous implantable cardioverter-defibrillator (ICD) system was developed to provide a life-saving defibrillation therapy that does not affect the heart and vasculature. The subcutaneous ICD is preferred over the transvenous ICD for patients with a history of recurrent infection presenting major life-threatening rhythms. In this case report, we describe the first successful intermuscular implantation of a completely subcutaneous ICD in a Japanese patient with pectus excavatum. There were no associated complications with the device implantation or lead positioning. Further, the defibrillation threshold testing did not pose any problem with the abnormal anatomy of the patient.
完全皮下植入式心脏复律除颤器(ICD)系统的开发是为了提供一种不影响心脏和血管系统的挽救生命的除颤治疗。对于有反复感染史且出现重大危及生命节律的患者,皮下ICD比经静脉ICD更受青睐。在本病例报告中,我们描述了首例在一名患有漏斗胸的日本患者中成功进行完全皮下ICD肌间植入的情况。该装置植入或导线定位均未出现相关并发症。此外,除颤阈值测试也未因患者的异常解剖结构而出现任何问题。